CXCL5 knockdown expression inhibits human bladder cancer T24 cells proliferation and migration

被引:27
作者
Zheng, Jiajia [1 ]
Zhu, Xi [2 ]
Zhang, Jie [1 ]
机构
[1] Peking Univ, Hosp 3, Dept Lab Med, Beijing 100191, Peoples R China
[2] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing, Peoples R China
关键词
CXCL5; Bladder cancer; T24; cells; Cells proliferation and migration; MESENCHYMAL TRANSITION; GENE-EXPRESSION; PROSTATE-CANCER; E-CADHERIN; POOR-PROGNOSIS; PEPTIDE ENA-78; OVEREXPRESSION; ANGIOGENESIS; PROGRESSION; CHEMOKINE;
D O I
10.1016/j.bbrc.2014.01.172
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CXCL5 (epithelial neutrophil activating peptide-78) which acts as a potent chemoattractant and activator of neutrophil function was reported to play a multifaceted role in tumorigenesis. To investigate the role of CXCL5 in bladder cancer progression, we examined the CXCL5 expression in bladder cancer tissues by real-time PCR and Western blot, additionally, we used shRNA-mediated silencing to generate stable CXCL5 silenced bladder cancer 124 cells and defined its biological functions. Our results demonstrated that mRNA and protein of CXCL5 is increased in human bladder tumor tissues and cell lines, downregulation of CXCL5 in T24 cells resulted in significantly decreased cell proliferation, migration and increased cell apoptosis in vitro through Snail, PI3K-AKT and ERK1/2 signaling pathways. These data suggest that CXCL5 is critical for bladder tumor growth and progression, it may represent a potential application in cancer diagnosis and therapy. (c) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 41 条
  • [1] Role of Raf in vascular protection from distinct apoptotic stimuli
    Alavi, A
    Hood, JD
    Frausto, R
    Stupack, DG
    Cheresh, DA
    [J]. SCIENCE, 2003, 301 (5629) : 94 - 96
  • [2] Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer
    Arenberg, DA
    Keane, MP
    DiGiovine, B
    Kunkel, SL
    Morris, SB
    Xue, YY
    Burdick, MD
    Glass, MC
    Iannettoni, MD
    Strieter, RM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) : 465 - 472
  • [3] Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction
    Baritaki, S.
    Chapman, A.
    Yeung, K.
    Spandidos, D. A.
    Palladino, M.
    Bonavida, B.
    [J]. ONCOGENE, 2009, 28 (40) : 3573 - 3585
  • [4] CXCL5 promotes prostate cancer progression
    Begley, Lesa A.
    Kasina, Sathish
    Mehra, Rohit
    Adsule, Shreelekha
    Admon, Andrew J.
    Lonigro, Robert J.
    Chinnaiyan, Arul
    Macoska, Jill
    [J]. NEOPLASIA, 2008, 10 (03): : 244 - 254
  • [5] Bladder cancer angiogenesis and metastasis-translation from murine model to clinical trial
    Black, Peter C.
    Dinney, Colin P. N.
    [J]. CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) : 623 - 634
  • [6] Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo
    Chen, JH
    Somanath, PR
    Razorenova, O
    Chen, WS
    Hay, N
    Bornstein, P
    Byzova, TV
    [J]. NATURE MEDICINE, 2005, 11 (11) : 1188 - 1196
  • [7] Dimberg J, 2007, INT J ONCOL, V31, P97
  • [8] VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail
    Evans, Andrew J.
    Russell, Ryan C.
    Roche, Olga
    Burry, T. Nadine
    Fish, Jason E.
    Chow, Vinca W. K.
    Kim, William Y.
    Saravanan, Arthy
    Maynard, Mindy A.
    Gervais, Michelle L.
    Sufan, Roxana I.
    Roberts, Andrew M.
    Wilson, Leigh A.
    Betten, Mark
    Vandewalle, Cindy
    Berx, Geert
    Marsden, Philip A.
    Irwin, Meredith S.
    Teh, Bin T.
    Jewett, Michael A. S.
    Ohh, Michael
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (01) : 157 - 169
  • [9] Gomes LR, 2011, CURR PHARM BIOTECHNO, V12, P1881
  • [10] The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer
    Hannelien, Verbeke
    Karel, Geboes
    Jo, Van Damme
    Sofie, Struyf
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1825 (01): : 117 - 129